It is also worthy to mention here that as α-CGRP has an important role in regulating regional organ blood flow in normal and pathophysiological conditions, it might be possible that migraine patients treated with CGRP-antagonists, that block CGRP-signaling, develop adverse side effects on heart and blood vessels. Here, CALCA is linked to migraine disorder.